FDA — authorised 6 August 2024
- Application: NDA218784
- Marketing authorisation holder: SERVIER
- Local brand name: VORANIGO
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Voranigo in United States
FDA authorised Voranigo on 6 August 2024
Marketing authorisations
FDA
- Marketing authorisation holder: SERVIER
- Status: approved
Voranigo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Voranigo approved in United States?
Yes. FDA authorised it on 6 August 2024; FDA has authorised it.
Who is the marketing authorisation holder for Voranigo in United States?
SERVIER holds the US marketing authorisation.